Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
about
Targeted nanoparticle for head and neck cancers: overview and perspectives.The EMT spectrum and therapeutic opportunities.Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.Neutrophils, a candidate biomarker and target for radiation therapy?
P2860
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@ast
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@en
type
label
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@ast
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@en
prefLabel
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@ast
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@en
P2093
P2860
P50
P1433
P1476
Phase II clinical study of val ...... Head and Neck-V-CHANCE trial.
@en
P2093
Andrea Ilaria Zotti
Annamaria Trotta
Antonio Daponte
Corrado Aversa
Elena Di Gennaro
Ernesta Cavalcanti
Ester Calogero
Ettore Pavone
Francesca Bruzzese
Francesco Caponigro
P2860
P2888
P356
10.1186/S12885-016-2957-Y
P407
P50
P577
2016-11-25T00:00:00Z
P6179
1000816421